IDYA - IDEAYA Biosciences, Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $-1.06
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$44.25
DETAILS
HIGH:
$60.00
LOW:
$30.00
MEDIAN:
$43.00
CONSENSUS:
$44.25
UPSIDE:
37.98%
Market Cap:
2.81B
Volume:
715,819
Avg Volume:
915,755
52 Week Range:
13.45-39.28
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.09
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
131
IPO Date:
2019-05-23
EPS (TTM):
-1.28
P/E Ratio:
-26.90
Revenue (TTM):
218.71M
Total Assets:
1.11B
Total Debt:
27.91M
Cash & Equiv:
112.83M
Rev Growth (5Y):
62.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-15.2%
Debt/Equity:
0.03
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $-0.94 | $-1.03 | +8.7% | $10.9M | $5.9M | +82.9% |
| 2025-11-04 | $1.33 | $-0.95 | +240.6% | $207.8M | $5.9M | +3395.1% |
| 2025-08-05 | $-0.88 | $-0.85 | -3.5% | — | $2.0M | — |
| 2025-05-06 | $-0.82 | $-0.75 | -9.3% | — | $2.4M | — |
| 2025-02-13 | $-1.49 | $-0.67 | -122.4% | $7.0M | $2.5M | +180.6% |
| 2024-11-04 | $-0.60 | $-0.67 | +10.4% | — | $4.3M | — |
| 2024-08-06 | $-0.68 | $-0.55 | -23.6% | — | $4.8M | — |
| 2024-05-07 | $-0.53 | $-0.53 | 0.0% | — | $4.5M | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 218.71M | 7.00M | 23.39M | 50.93M | 27.94M | 19.54M | 0 | 0 | 0 |
| Net Income | (113.70M) | (274.48M) | (112.96M) | (58.66M) | (49.76M) | (34.49M) | (41.98M) | (34.35M) | (11.86M) |
| EPS | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.31 | -1.90 | -2.41 | -0.83 |
| Total Assets | 1.11B | 1.12B | 649.32M | 387.97M | 381.35M | 298.27M | 113.00M | 96.54M | 17.48M |
| Total Debt | 27.91M | 19.17M | 2.87M | 3.48M | 5.18M | 6.72M | 6.77M | 0 | 3.21M |
| Cash & Equivalents | 112.83M | 84.38M | 157.02M | 68.63M | 92.05M | 72.04M | 34.07M | 20.50M | 5.96M |
| Operating Cash Flow | (71.10M) | (247.58M) | (115.22M) | (87.17M) | (55.78M) | 55.46M | (39.31M) | (27.62M) | (12.22M) |
| Free Cash Flow | (73.47M) | (251.44M) | (117.59M) | (90.62M) | (58.42M) | 54.97M | (40.67M) | (29.33M) | (13.98M) |
| FCF per Share | -0.83 | -3.08 | -2.04 | -2.19 | -1.66 | 2.22 | -2.01 | -2.06 | -0.98 |
| Book Value | 1.02B | 1.06B | 621.09M | 349.45M | 301.51M | 198.27M | 100.40M | (48.95M) | (15.74M) |
| Cash & ST Investments | 639.39M | 676.32M | 525.11M | 364.83M | 246.77M | 283.58M | 98.96M | 89.96M | 13.16M |
| ROC Equity | -0.11 | -0.26 | -0.18 | -0.17 | -0.17 | -0.17 | -0.42 | N/A | N/A |